HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association between IA-2 autoantibody epitope specificities and age of onset in Japanese patients with autoimmune diabetes.

Abstract
The IA-2 is a major autoantigen of type 1 diabetes belonging to the protein tyrosine phosphatase family. We report on the humoral autoimmunity to an alternatively-spliced variant of IA-2 (IA-2 variant) and autoimmune-mediated diabetes age of onset association with IA-2 autoantibody epitope specificities, in 144 recent-onset patients with type 1 diabetes and 54 GAD autoantibody-positive patients with type 2 diabetes. The cytoplasmic domain of IA-2 (IA-2ic) detected a somewhat greater proportion of patients expressing autoantibodies than IA-2 variant (56%vs. 52% of patients with type 1 diabetes and 17%vs. 9% of GAD autoantibody-positive patients with type 2 diabetes). Conversely, only 1% of IA-2 variant autoantibody-positive patients failed to react to IA-2ic construct. Among 80 patients with type 1 diabetes who were positive for autoantibodies to IA-2ic, 8% recognized the juxtamembrane region (JM, representing amino acids 601-629) only, 64% bound the protein tyrosine phosphatase (PTP)-like domain of IA-2 only, and 29% bound both JM and PTP epitopes. Autoantibodies to the PTP-like domain were prevalent in children and adolescents with type 1 diabetes. The age of disease onset in patients with IA-2JM autoantibodies only, was significantly higher than those in patients reacted with the PTP-like domain of IA-2 (P< 0.02). Among GAD autoantibody-positive patients with type 2 diabetes reacted with IA-2ic, 44% bound the JM region only, and 33% bound epitopes in the PTP-like domain only; 22% had autoantibodies to both regions. The frequency of GAD autoantibody-positive patients with type 2 diabetes positive for autoantibodies to the JM region only, was significantly higher than that in patients with type 1 diabetes (P< 0.01). IA-2PTP autoantibodies were significantly associated with HLA-DR4, while the additional reactivity to IA-2JM was associated with HLA-DR9 allele. These results suggest that autoantibody recognition of IA-2 epitopes in autoimmune diabetes is associated with age of disease onset, which may reflect the intensity of the beta-cell destruction process.
AuthorsE Kawasaki, Y Sera, N Fujita, M Yamauchi, M Ozaki, T Abe, K Yamakawa, S Uotani, H Takino, H Yamasaki, Y Yamaguchi, Y Uchigata, N Matsuura, K Eguchi
JournalJournal of autoimmunity (J Autoimmun) Vol. 17 Issue 4 Pg. 323-31 (Dec 2001) ISSN: 0896-8411 [Print] England
PMID11771957 (Publication Type: Journal Article)
CopyrightCopyright 2001 Academic Press.
Chemical References
  • Autoantibodies
  • Epitopes
  • ICA512 autoantibody
Topics
  • Adolescent
  • Adult
  • Age of Onset
  • Aged
  • Antibody Specificity (immunology)
  • Autoantibodies (immunology)
  • Child
  • Child, Preschool
  • Diabetes Mellitus, Type 1 (epidemiology, immunology, physiopathology)
  • Epitopes (immunology)
  • Female
  • Humans
  • Japan (epidemiology)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: